About Swissfillon
Swissfillon is a Healthcare company based in Visp (Switzerland) founded in 2013, and was acquired by ten23 health in October 2021. End-to-end fill and finish consulting and management services are provided. Its focus areas include Biopharma Outsourcing, CDMO, Diversified and Fill and Finish.
Company details
Swissfillon a spinoff of the biopharma engineering company, pixon engineering. The company offers fill finish project consulting and project management services spanning - Process development and validation; Primary packaging development in glass rubber with a customized container and stopper; and Secondary packaging. From beginning of 2017, the company provides the following services at 1-100lt GMP batch size - Compounding; Liquid aseptic filling (lyophilisation in second phase) with the possibility of inert gas purge and overlay: Syringe filling: 0.5ml to 5ml, Vial filling: 2ml to 20ml, Cartridge filling: Up to 3ml, Up to 20000 units batch day, Custom blistering and secondary packaging services. Swissfillon aims to be a one-stop-shop partner for all fill finish related aspects through all clinical phases to early commercial supply.
- Headquarters Visp, Switzerland
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website swissfillon.com
- Social LinkedIn X
- Acquired by ten23 health (Oct 2021)
- Investors
- Acquired byten23 health
(Oct 2021)
Investors in Swissfillon
Swissfillon has secured backing from 1 investor. Prominent investors backing the company include ten23 health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biopharma research, development, manufacturing, testing, and consulting services are provided. | 2021 | ten23.health | Basel, Switzerland |
Investor details for Swissfillon
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Swissfillon
2 dated milestones of Swissfillon across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Swissfillon is founded.
- Exit Acquired by ten23 health.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Swissfillon
Complete news archive for Swissfillon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Swissfillon
Swissfillon was founded in 2013.
Swissfillon is headquartered in Visp, Switzerland. It is registered at Visp, Valais, Switzerland.
Swissfillon a spinoff of the biopharma engineering company, pixon engineering. The company offers fill finish project consulting and project management services spanning - Process development and validation; Primary packaging development in glass rubber with a customized container and stopper; and Secondary packaging. From beginning of 2017, the company provides the following services at 1-100lt GMP batch size - Compounding; Liquid aseptic filling (lyophilisation in second phase) with the possibility of inert gas purge and overlay: Syringe filling: 0.5ml to 5ml, Vial filling: 2ml to 20ml, Cartridge filling: Up to 3ml, Up to 20000 units batch day, Custom blistering and secondary packaging services. Swissfillon aims to be a one-stop-shop partner for all fill finish related aspects through all clinical phases to early commercial supply.
Swissfillon has 1 investor. Key investors include ten23 health.
Yes. Swissfillon was acquired by ten23 health in October 2021.

